pneumococcal capsular polysaccharide antigen serotype 31

Spain

Drugs containing this active substance

CAPVAXIVE SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE

It is a vaccine that helps protect adults aged 18 and older against diseases caused by the pneumococcus bacteria, such as pneumonia, meningitis, and bloodstream infections.

Form: solution for injection in a pre-filled syringe

Active substance	Dosage
pneumococcal capsular polysaccharide antigen serotype 3	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 6a	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 7f	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 8	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 9n	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 10a	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 11a	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 12f	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 15a	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 15b	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 16f	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 17f	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 19a	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 20a	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 22f	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 23a	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 23b	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 24f	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 31	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 33f	4 µg/dosis
pneumococcal capsular polysaccharide antigen serotype 35b	4 µg/dosis

ATC: J07A J07AL J07AL02

Manufacturer: Merck Sharp & Dohme B.V.